| 1 | [SID103568038] | Unspecified | | | Antihyperalgesic activity in Sprague-Dawley rat assessed as lesioned paw pressure threshold at 30 ug/kg, icv after 30 mins [AID322667, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103568038 | | CID | 71157 | | Outcome | Unspecified | | BioAssay | Antihyperalgesic activity in Sprague-Dawley rat assessed as lesioned paw pressure threshold at 30 ug/kg, icv after 30 mins | | AID | 322667 | | BioAssay type | Literature | | Target | | | PubMed | 18171618 | | Data Table |  |
|
| 2 | [SID103568038] | Unspecified | | | Antihyperalgesic activity in Sprague-Dawley rat assessed as lesioned paw pressure threshold at 30 ug/kg, icv after 45 mins [AID322668, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103568038 | | CID | 71157 | | Outcome | Unspecified | | BioAssay | Antihyperalgesic activity in Sprague-Dawley rat assessed as lesioned paw pressure threshold at 30 ug/kg, icv after 45 mins | | AID | 322668 | | BioAssay type | Literature | | Target | | | PubMed | 18171618 | | Data Table |  |
|
| 3 | [SID103568038] | Unspecified | | | Antihyperalgesic activity in Sprague-Dawley rat assessed as lesioned paw pressure threshold at 30 ug/kg, icv after 60 mins [AID322669, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103568038 | | CID | 71157 | | Outcome | Unspecified | | BioAssay | Antihyperalgesic activity in Sprague-Dawley rat assessed as lesioned paw pressure threshold at 30 ug/kg, icv after 60 mins | | AID | 322669 | | BioAssay type | Literature | | Target | | | PubMed | 18171618 | | Data Table |  |
|
| 4 | [SID103568038] | Unspecified | | | Inhibition of human FAAH at 1 uM [AID468443, Type: Literature] | Fatty-acid amide hydrolase 1 [gi:60416391] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103568038 | | CID | 71157 | | Outcome | Unspecified | | BioAssay | Inhibition of human FAAH at 1 uM | | AID | 468443 | | BioAssay type | Literature | | Target | Fatty-acid amide hydrolase 1 [gi:60416391] | | PubMed | 19850474 | | Data Table |  |
|
| 5 | [SID90340767] | Inactive | Potency | | qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1) [AID488816, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1) | | AID | 488816 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 6 | [SID90340767] | Inactive | Potency | | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 7 | [SID90340767] | Inactive | Potency | | Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells [AID2660, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells | | AID | 2660 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 8 | [SID90340767] | Inactive | Potency | | Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells [AID2660, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells | | AID | 2660 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 9 | [SID90340767] | Inactive | Potency | | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells [AID2666, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells | | AID | 2666 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 10 | [SID90340767] | Inactive | Potency | | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells [AID2666, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells | | AID | 2666 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 11 | [SID90340767] | Inactive | Potency | | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells [AID2667, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells | | AID | 2667 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 12 | [SID90340767] | Inactive | Potency | | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells [AID2667, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells | | AID | 2667 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 13 | [SID90340767] | Inactive | Potency | | Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells [AID2668, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells | | AID | 2668 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 14 | [SID90340767] | Inactive | Potency | | Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells [AID2668, Type: confirmatory] | MTOR gene product [Homo sapiens] [gi:4826730] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells | | AID | 2668 | | BioAssay type | confirmatory | | Target | MTOR gene product [Homo sapiens] [gi:4826730] | | PubMed | | | Data Table |  |
|
| 15 | [SID90340767] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 16 | [SID90340767] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 17 | [SID90340767] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists: LOPAC Validation [AID624148, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists: LOPAC Validation | | AID | 624148 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 18 | [SID90340767] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists: LOPAC Validation [AID624148, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists: LOPAC Validation | | AID | 624148 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 19 | [SID90340767] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 20 | [SID90340767] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 21 | [SID90340767] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation [AID624146, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation | | AID | 624146 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 22 | [SID90340767] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 23 | [SID90340767] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 24 | [SID90340767] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 25 | [SID90340767] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 26 | [SID90340767] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: Validation [AID493153, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: Validation | | AID | 493153 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 27 | [SID90340767] | Inactive | Potency | | qHTS of Nrf2 Activators: LOPAC Validation [AID624149, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators: LOPAC Validation | | AID | 624149 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 28 | [SID90340767] | Inactive | Potency | | qHTS of Nrf2 Activators: LOPAC Validation [AID624149, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators: LOPAC Validation | | AID | 624149 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 29 | [SID90340767] | Inactive | Potency | | qHTS of Nrf2 Activators: LOPAC Validation [AID624149, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators: LOPAC Validation | | AID | 624149 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 30 | [SID90340767] | Inactive | Potency | | qHTS of Nrf2 Activators: LOPAC Validation [AID624149, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Nrf2 Activators: LOPAC Validation | | AID | 624149 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 31 | [SID90340767] | Inactive | Potency | | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 32 | [SID48414094] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 48414094 | | CID | 71157 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results | | AID | 1208 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID48414094] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 48414094 | | CID | 71157 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results | | AID | 1205 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID48414094] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results [AID1199, Type: other] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 48414094 | | CID | 71157 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results | | AID | 1199 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID48414094] | Inactive | | | DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 48414094 | | CID | 71157 | | Outcome | Inactive | | BioAssay | DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results | | AID | 1189 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID90340767] | Inactive | Potency | | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion [AID485298, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion | | AID | 485298 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID90340767] | Inactive | Potency | | qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling [AID485345, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling | | AID | 485345 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID90340767] | Inactive | Potency | | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID90340767] | Inactive | Potency | | qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay [AID588349, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay | | AID | 588349 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID144207070] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 144207070 | | CID | 71157 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID144207070] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 144207070 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID144207070] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 144207070 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID144207070] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 144207070 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID121361300] | Inactive | | | A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus [AID651828, Type: other] | Nucleoprotein [gi:127925] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 121361300 | | CID | 71157 | | Outcome | Inactive | | BioAssay | A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus | | AID | 651828 | | BioAssay type | other | | Target | Nucleoprotein [gi:127925] | | PubMed | | | Data Table |  |
|
| 45 | [SID90340767] | Inactive | Potency | | Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Biochemical firefly luciferase enzyme assay for NPC | | AID | 624030 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 46 | [SID90340767] | Inactive | Potency | | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 47 | [SID90340767] | Inactive | Potency | | qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria [AID485295, Type: confirmatory] | DNA polymerase III [Bacillus subtilis] [gi:30027657] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria | | AID | 485295 | | BioAssay type | confirmatory | | Target | DNA polymerase III [Bacillus subtilis] [gi:30027657] | | PubMed | | | Data Table |  |
|
| 48 | [SID90340767] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 49 | [SID90340767] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation [AID624147, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 90340767 | | CID | 71157 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation | | AID | 624147 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 50 | [SID144207070] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 144207070 | | CID | 71157 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|